Hyperhomocysteinemia lowers serum testosterone concentration via impairing testosterone production in Leydig cells

Cell Biol Toxicol. 2023 Dec;39(6):3077-3100. doi: 10.1007/s10565-023-09819-4. Epub 2023 Jul 27.

Abstract

Hyperhomocysteinemia (HHcy) plays a salient role in male infertility. However, whether HHcy interferes with testosterone production remains inconclusive. Here, we reported a lower serum testosterone level in HHcy mice. Single-cell RNA sequencing revealed that genes related to testosterone biosynthesis, together with nuclear receptor subfamily 5 group A member 1 (Nr5a1), a key transcription factor for steroidogenic genes, were downregulated in the Leydig cells (LCs) of HHcy mice. Mechanistically, Hcy lowered trimethylation of histone H3 on lysine 4 (H3K4me3), which was bound on the promoter region of Nr5a1, resulting in downregulation of Nr5a1. Intriguingly, we identified an unknown cell cluster annotated as Macrophage-like Leydig cells (McLCs), expressing both LCs and macrophages markers. In HHcy mice, McLCs were shifted toward pro-inflammatory phenotype and thus promoted inflammatory response in LC. Betaine supplementation rescued the downregulation of NR5A1 and restored the serum testosterone level in HHcy mice. Overall, our study highlights an etiological role of HHcy in LCs dysfunction.

Keywords: Hyperhomocysteinemia; Leydig cell; Single-cell RNA sequencing; Testosterone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hyperhomocysteinemia* / metabolism
  • Leydig Cells* / metabolism
  • Macrophages / metabolism
  • Male
  • Mice
  • Testosterone
  • Transcription Factors / genetics

Substances

  • Testosterone
  • Transcription Factors